A Single-Dose, 1-Period, 1-Treatment Pilot Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone Under Fasting Conditions

This study has been completed.

Sponsor:

Collaborator:

Information provided by:

Nanotherapeutics, Inc.

ClinicalTrials.gov Identifier:

NCT00880841

First received: April 13, 2009

Last updated: May 5, 2009

Last verified: May 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2009
Primary Completion Date:	May 2009 (Final data collection date for primary outcome measure)